2026· American Journal of Student Research· 0 citations
Abstract
Early-onset colorectal cancer (EOCRC), diagnosed before age 50 years, is increasing in many
countries. This narrative review examines whether dietary carcinogen exposure or chronic inflammation
is better supported as a contributor, and whether the two can be separated at all. Mechanistic studies
describe three diet-linked routes to colonic DNA damage: heat-generated mutagens (heterocyclic amines
and polycyclic aromatic hydrocarbons), heme-associated nitrosation and lipid peroxidation, and colibactin
produced by pks-positive Escherichia coli. This work establishes biological plausibility and genotoxicity,
but it does not show that these exposures caused the population-level rise. Ecological data show
EOCRC increasing in regions with Westernized diets, whereas diagnosed pediatric inflammatory bowel
disease (IBD) corresponds only loosely with EOCRC patterns. That comparison is limited by temporal
misalignment, registry differences, and the fact that an IBD diagnosis does not capture subclinical or
metabolic inflammation. Rising early-onset gastric cancer and falling colitis-associated colorectal cancer
fit a dietary-exposure hypothesis but do not test it. Colibactin-producing bacteria and inflammation may
reinforce each other, so the two factors are unlikely to act independently. Current evidence therefore
supports dietary carcinogen exposure as a plausible leading contributor and inflammation as a possible
amplifier, but this ordering remains a hypothesis. Priorities include defining exposure windows,
quantifying dose-response relationships, and improving registry data.
Clinically, EOCRC highlights limitations of age-based screening and the need for improved symptom recognition, earlier diagnosis, and risk-stratified screening approaches, and prevention strategies should extend beyond midlife screening to target modifiable exposures earlier in life.
Amit Syal, S. J. Cohen· Clinical colorectal cancer· 0 citations
Early-onset colorectal cancer (EOCRC), defined as colorectal cancer diagnosed before age 50, has become an increasing global public health concern. Incidence rates have risen among younger adults in many countries, despite stable or declining rates in older populations. This review examines global EOCRC epidemiology, p...
Kacper Wrzosek, Agata Koba, Pola Bakalczuk et al.· Cancers· 0 citations
Early-onset colorectal cancer (EOCRC), conventionally defined as colorectal cancer (CRC) diagnosed before age 50, is increasing across multiple regions despite stable or declining incidence in older adults. This review synthesises current evidence on its epidemiology, aetiology, biology, diagnosis, treatment and surviv...
A. Lefas, A. Athauda, N. Joharatnam-Hogan· Academia Oncology· 0 citations
A retrospective secondary analysis of comprehensive genomic and immune profiling data from 1737 patients with colorectal cancer tested showed that tumours arising in patients with EOCRC had lower tumour mutational burden than tumours diagnosed as LOCRC, whereas other immune-related biomarkers did not remain significant...
A. Nogueira, Jennifer Brondon, Konstantin Haradinov et al.· Oncology and Therapy· 0 citations
Early-onset colorectal cancer (EOCRC), defined as colorectal cancer in individuals under 50 years old, is a growing global epidemic, with incidence and mortality rates steadily increasing over the past several decades. Although EOCRC has been linked to established colorectal cancer risk factors, its underlying causes r...
Niti Jani, Valerie G. Hinsch, Mia Joseph et al.· Carcinogenesis· 0 citations
This review synthesizes current evidence on the TiME of EOCRC and contrast it with that of conventional LOCRC, and explores how these insights inform immune-based prevention and immunotherapy strategies, including checkpoint blockade and rational combinations in the predominant microsatellite-stable EOCRC population.
José Perea, María González-Sanmartín, M. Coiras et al.· Cancer immunology research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.